Literature DB >> 11015453

Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis.

J C Lindsey1, M E Lusher, C J McDermott, K D White, E Reid, D C Rubinsztein, R Bashir, J Hazan, P J Shaw, K M Bushby.   

Abstract

BACKGROUND: Hereditary spastic paraparesis is a genetically heterogeneous condition. Recently, mutations in the spastin gene were reported in families linked to the common SPG4 locus on chromosome 2p21-22.
OBJECTIVES: To study a population of patients with hereditary spastic paraparesis for mutations in the spastin gene (SPG4) on chromosome 2p21-22.
METHODS: DNA from 32 patients (12 from families known to be linked to SPG4) was analysed for mutations in the spastin gene by single strand conformational polymorphism analysis and sequencing. All patients were also examined clinically.
RESULTS: Thirteen SPG4 mutations were identified, 11 of which are novel. These mutations include missense, nonsense, frameshift, and splice site mutations, the majority of which affect the AAA cassette. We also describe a nucleotide substitution outside this conserved region which appears to behave as a recessive mutation.
CONCLUSIONS: Recurrent mutations in the spastin gene are uncommon. This reduces the ease of mutation detection as a part of the diagnostic work up of patients with hereditary spastic paraparesis. Our findings have important implications for the presumed function of spastin and schemes for mutation detection in HSP patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015453      PMCID: PMC1757167          DOI: 10.1136/jmg.37.10.759

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

2.  Classification of the hereditary ataxias and paraplegias.

Authors:  A E Harding
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

3.  Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss.

Authors:  X Z Liu; X J Xia; L R Xu; A Pandya; C Y Liang; S H Blanton; S D Brown; K P Steel; W E Nance
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

4.  Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q.

Authors:  J Hazan; C Lamy; J Melki; A Munnich; J de Recondo; J Weissenbach
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

Review 5.  Hereditary spastic paraplegias.

Authors:  A E Harding
Journal:  Semin Neurol       Date:  1993-12       Impact factor: 3.420

6.  Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.

Authors:  N Fonknechten; D Mavel; P Byrne; C S Davoine; C Cruaud; D Bönsch; D Boentsch; D Samson; P Coutinho; M Hutchinson; P McMonagle; J M Burgunder; A Tartaglione; O Heinzlef; I Feki; T Deufel; N Parfrey; A Brice; B Fontaine; J F Prud'homme; J Weissenbach; A Dürr; J Hazan
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

7.  Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q.

Authors:  J K Fink; C T Wu; S M Jones; G B Sharp; B M Lange; A Lesicki; T Reinglass; T Varvil; B Otterud; M Leppert
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.

Authors:  P Saugier-Veber; A Munnich; D Bonneau; J M Rozet; M Le Merrer; R Gil; O Boespflug-Tanguy
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

9.  Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p.

Authors:  J Hazan; B Fontaine; R P Bruyn; C Lamy; J C van Deutekom; C S Rime; A Dürr; J Melki; O Lyon-Caen; Y Agid
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

10.  Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity.

Authors:  A Hentati; M A Pericak-Vance; W Y Hung; S Belal; N Laing; R M Boustany; F Hentati; M Ben Hamida; T Siddique
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

View more
  38 in total

1.  A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set.

Authors:  Tara C Matise; Ravi Sachidanandam; Andrew G Clark; Leonid Kruglyak; Ellen Wijsman; Jerzy Kakol; Steven Buyske; Buena Chui; Patrick Cohen; Claudia de Toma; Margaret Ehm; Stephen Glanowski; Chunsheng He; Jeremy Heil; Kyriacos Markianos; Ivy McMullen; Margaret A Pericak-Vance; Arkadiy Silbergleit; Lincoln Stein; Michael Wagner; Alexander F Wilson; Jeffrey D Winick; Emily S Winn-Deen; Carl T Yamashiro; Howard M Cann; Eric Lai; Arthur L Holden
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

2.  No correlation between amount of aberrant transcript and severity of phenotype in hereditary spastic paraplegia patients with a c.1242A > G splice mutation in the SPG4 gene.

Authors:  Simone M Sauter; Nadine Dörwald; Wolfgang Engel; Jürgen Neesen
Journal:  J Neurol       Date:  2005-12-13       Impact factor: 4.849

3.  The AAA + ATPase Thorase is neuroprotective against ischemic injury.

Authors:  Jianmin Zhang; Jia Yang; Huaishan Wang; Omar Sherbini; Matthew J Keuss; George Ke Umanah; Emily Ling-Lin Pai; Zhikai Chi; Kaisa Ma Paldanius; Wei He; Hong Wang; Shaida A Andrabi; Ted M Dawson; Valina L Dawson
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-16       Impact factor: 6.200

4.  Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Toshihiro Hayashi; Kayoko Saito; Hirokazu Furuya; Mitsunori Watanabe; Miho Murata; Mikiya Suzuki; Akira Sugiura; Setsu Sawai; Kazumoto Shibuya; Naohisa Ueda; Yaeko Ichikawa; Ichiro Kanazawa; Jun Goto; Shoji Tsuji
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

5.  Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia.

Authors:  Joanna M Solowska; James Y Garbern; Peter W Baas
Journal:  Hum Mol Genet       Date:  2010-04-29       Impact factor: 6.150

6.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.

Authors:  I K Svenson; A E Ashley-Koch; P C Gaskell; T J Riney; W J Cumming; H M Kingston; E L Hogan; R M Boustany; J M Vance; M A Nance; M A Pericak-Vance; D A Marchuk
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

7.  Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells.

Authors:  Kyle R Denton; Chongchong Xu; Harsh Shah; Xue-Jun Li
Journal:  Front Biol (Beijing)       Date:  2016-09-28

8.  Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.

Authors:  Ingrid K Svenson; Mark T Kloos; P Craig Gaskell; Martha A Nance; James Y Garbern; Shin-ichi Hisanaga; Margaret A Pericak-Vance; Allison E Ashley-Koch; Douglas A Marchuk
Journal:  Neurogenetics       Date:  2004-07-10       Impact factor: 2.660

9.  Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements.

Authors:  Mark Braschinsky; Riin Tamm; Christian Beetz; Elena Sachez-Ferrero; Elve Raukas; Siiri-Merike Lüüs; Katrin Gross-Paju; Catherine Boillot; Federico Canzian; Andres Metspalu; Sulev Haldre
Journal:  BMC Neurol       Date:  2010-03-09       Impact factor: 2.474

10.  Congenital bovine spinal dysmyelination is caused by a missense mutation in the SPAST gene.

Authors:  Bo Thomsen; Peter H Nissen; Jørgen S Agerholm; Christian Bendixen
Journal:  Neurogenetics       Date:  2009-08-28       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.